Trade Summary

6 days ago, Van Tuyl Christopher, serving as GC at Immunovant, Inc. (IMVT), sold 5,165 shares at $24.83 per share, for a total transaction value of $128,247.00. Following this transaction, Van Tuyl Christopher now holds 183,231 shares of IMVT.

This sale represents a 3.00% decrease in Van Tuyl Christopher's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, April 8, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 10, 2026, 2 days after the trade was made.

Immunovant, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.